Sei Investments CO Igm Biosciences, Inc. Transaction History

Sei Investments CO

  • $74.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$65.76 - $90.65 $164,728 - $227,078
-2,505 Closed
0 $0
Q2 2021

Aug 06, 2021
BUY
$57.98 - $96.6 $145,239 - $241,983
2,505 New
2,505 $208,000
Q4 2020

Feb 08, 2021
SELL
$47.41 - $115.03 $138,437 - $335,887
-2,920 Closed
0 $0
Q3 2020

Nov 06, 2020
BUY
$43.0 - $84.01 $125,560 - $245,309
2,920 New
2,920 $216,000

Others Institutions Holding IGMS

# of Institutions
81
Shares Held
20.7M
Call Options Held
68K
Put Options Held
52.2K
View Full List

About IGM Biosciences, Inc.

IGMS Quotes by TradingView
  • Ticker IGMS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,969,000
  • Market Cap $189M
  • Description
  • IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...
More about IGMS
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email